Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials01:16

Clinical Trials

8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

642
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
642
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.9K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Proportionality of Secondary Tricuspid Regurgitation on Outcomes After Tricuspid Transcatheter Edge-to-Edge Repair.

Circulation. Cardiovascular interventions·2026
Same author

Treatment of infected endografts after thoracic endovascular aortic repair: a systematic review.

Science progress·2026
Same author

Ascending aortic aneurysm and dissection risk: focus on aortic height index.

Interdisciplinary cardiovascular and thoracic surgery·2025
Same author

[Dilation of the ascending aorta: diagnosis, clinical presentation, and indication for surgery. The crucial role of the cardiologist].

Giornale italiano di cardiologia (2006)·2024
Same author

Thoracic Endovascular Aortic Repair For The Management of Aorto-Esophageal Fistulae: A Systematic Review.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2024
Same author

TRIVALVE Score: A Risk Score for Mortality/Hospitalization Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention.

JACC. Cardiovascular interventions·2024

Related Experiment Video

Updated: May 3, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

722

New devices for TAVI: technologies and initial clinical experiences.

Maurizio Taramasso1, Alberto Pozzoli1, Azeem Latib1

  • 1Cardiothoracic Department, San Raffaele University Hospital, Via Olgettina 60, 20122 Milan, Italy.

Nature Reviews. Cardiology
|January 22, 2014
PubMed
Summary

Transcatheter aortic valve implantation (TAVI) has advanced, but first-generation devices have unresolved complications. New TAVI technologies aim to improve outcomes and expand patient eligibility for aortic stenosis treatment.

More Related Videos

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
05:51

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein

Published on: January 13, 2026

395
Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring
11:17

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

Published on: April 3, 2015

11.2K

Related Experiment Videos

Last Updated: May 3, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

722
Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
05:51

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein

Published on: January 13, 2026

395
Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring
11:17

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

Published on: April 3, 2015

11.2K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Transcatheter aortic valve implantation (TAVI) has transformed aortic stenosis treatment for high-risk patients.
  • First-generation TAVI devices present ongoing challenges, including bleeding, vascular issues, neurological events, arrhythmias, and paravalvular leakage.

Purpose of the Study:

  • To review advancements in new-generation TAVI devices.
  • To discuss technological improvements addressing limitations of earlier TAVI systems.
  • To provide an overview of initial clinical data on next-generation TAVI technologies.

Main Methods:

  • Review of current literature and clinical evaluations of new TAVI devices.
  • Analysis of technological modifications in next-generation TAVI systems.
  • Synthesis of initial clinical reports on novel transcatheter valvular technologies.

Main Results:

  • New TAVI devices incorporate features for repositioning, reduced paravalvular leakage, and low-profile delivery systems.
  • Early clinical evaluations of these next-generation devices are underway.
  • Technological refinements aim to mitigate complications associated with earlier TAVI procedures.

Conclusions:

  • Further technological innovation in TAVI is crucial for addressing unresolved issues.
  • Next-generation TAVI devices hold promise for improved patient outcomes and expanded indications.
  • Continued clinical evaluation is necessary to validate the benefits of new TAVI technologies for aortic stenosis treatment.